We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
XIIDRA (Shire Australia Pty Ltd)
Product name
XIIDRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
216 working days (255)
Active ingredients
lifitegrast
Registration type
NCE/NBE
Indication
XIIDRA (eye drops) is indicated for the treatment of moderate to severe dry eye disease in adults for whom prior use of artificial tears has not been sufficient.